PYC THERAPEUTICS ORDINARY (PYC) Short Interest
PYC THERAPEUTICS ORDINARY (ASX:PYC) had 0.34% of shares reported as short positions as of 16 July 2026, representing 3,347,266 shares. PYC THERAPEUTICS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Pyc Therapeutics
PYC Therapeutics is a clinical-stage biotech company focused on developing RNA therapies to address genetic diseases. Their proprietary RNA delivery platform aims to provide safer and more effective treatments by targeting the underlying causes of these diseases. The company is advancing a pipeline of novel therapies for eye, central nervous system, and kidney diseases.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4PYC intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Pyc Therapeutics
Latest PYC news
All newsAbout
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss PYC
Start a research thread or post the first pulse update